OxSonics Therapeutics Company
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Technology:
Others
Industry:
PharmTech
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2013
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership